Friedberg Ezra M

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-06-17	2026-06-15	Channel Therapeutics Corp (CHRO)	PlS Planned sale	5,682 -45.1% 454.34 US$2,624,808	5,682 -45.1%	454.34	US$2,624,808
2026-06-17	2026-06-15	Channel Therapeutics Corp (CHRO)	PlS Planned sale	95,786 +5.4% 475.66 US$2,236,678	95,786 +5.4%	475.66	US$2,236,678
2026-04-06	2026-04-02	Channel Therapeutics Corp (CHRO)	PlS Planned sale	6,133 +13.5% 374.41 US$742,209	6,133 +13.5%	374.41	US$742,209
2026-04-06	2026-04-02	Channel Therapeutics Corp (CHRO)	PlS Planned sale	293 -0.4% 20.51 US$6,010	293 -0.4%	20.51	US$6,010
2025-11-26	2025-11-25	Channel Therapeutics Corp (CHRO)	S Sale	2,000 -6.2% 28.01 US$56,010	2,000 -6.2%	28.01	US$56,010
2025-11-26	2025-11-25	Channel Therapeutics Corp (CHRO)	S Sale	1 -0.0% 28.50 US$28	1 -0.0%	28.50	US$28
2025-11-26	2025-11-25	Channel Therapeutics Corp (CHRO)	S Sale	2,000 -5.9% 28.14 US$56,270	2,000 -5.9%	28.14	US$56,270
2025-11-26	2025-11-25	Channel Therapeutics Corp (CHRO)	S Sale	5,999 -15.0% 28.00 US$167,972	5,999 -15.0%	28.00	US$167,972